News for AVTR Stock

Avantor® to Host Second Quarter 2025 Earnings Call on Friday, August 1, 2025 Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference Avantor® to Participate in Bank of America Securities 2025 Health Care Conference Avantor® Announces CEO Transition Avantor® Reports First Quarter 2025 Results Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025 Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025 Avantor® to Present at TD Cowen's 45th Annual Health Care Conference Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq’s Novel Surface Treatment Technology Avantor® Reports Fourth Quarter and Full Year 2024 Results TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025 Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors Avantor® Reports Third Quarter 2024 Results Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges Audax Private Equity Completes Carveout of Avantor, Inc.’s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions Avantor® Closes Previously Announced Divestiture of its Clinical Services Business Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality Management Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024 Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase Agreement Avantor® Participates in BioProcess International 2024 Conference Scientific Program and Exhibition Avantor® Achieves Bronze Medal from EcoVadis for Sustainability Performance Avantor® to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference Audax Private Equity to Acquire Avantor’s Clinical Services Business Avantor® Enters into Definitive Agreement to Divest Clinical Services Business to Audax Private Equity Avantor® Reports Second Quarter 2024 Results Avantor® Announces New J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease Avantor® to Host Second Quarter 2024 Earnings Call on Friday, July 26, 2024 Avantor® Appoints Corey Walker as President of Laboratory Solutions Avantor® Releases 2024 Science for Goodness Sustainability Report Avantor® to Participate in Goldman Sachs Global Healthcare Conference Avantor® to Participate in Bernstein's 40th Annual Strategic Decisions Conference Avantor® to Participate in BofA Securities 2024 Health Care Conference Avantor® Reports First Quarter 2024 Results Avantor® to Host First Quarter 2024 Earnings Call on Friday, April 26, 2024 Avantor® Celebrates Supplier Award Honorees at 2024 European Sales Conference Avantor® to Participate in the 44th Annual TD Cowen Health Care Conference Avantor® Reports Fourth Quarter and Full Year 2023 Results Board Courage in Advancing Workplace Equity a Critical Component of Resilient Companies Avantor® to Report Fourth Quarter and Full Year 2023 Earnings on Wednesday, February 14, 2024 Avantor® Recognizes Supplier Award Winners at 2024 Americas Sales Conference Avantor® to Participate in the 42nd Annual J.P. Morgan Healthcare Conference Avantor® Hosts Investor Day, Announces New Strategic Operating Model to Drive Growth and Productivity Avantor(R) Receives Top Score on Human Rights Campaign Foundation's 2023–2024 Corporate Equality Index Avantor® Receives Top Score on Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index Avantor® to Host Investor Day on December 8, 2023 Avantor® to Participate in the 6th Annual Evercore ISI HealthCONx Conference The Pharmaceutical Supply Chain Addresses The Renewable Energy Transition | Part 2 Avantor® Reports Third Quarter 2023 Results Banks and Their Boards Need a More Strategic Approach to Responding to Societal Challenges Avantor® to Host Third Quarter 2023 Earnings Call on Friday, October 27, 2023 Avantor® Announces Ger Brophy to Retire in 2024; Benoit Gourdier Appointed EVP, Biopharma Production Avantor® Announces New Scientific Advisory Board Avantor Impact Story: Reducing Waste in Everyday Shipment Handling Avantor® Partners with Tobin Scientific to Provide End-to-End Solution for Research Lab Relocations, Sample Transport, and GMP Storage Services Avantor® Reports Second Quarter 2023 Results Avantor Earns Bronze Medal from EcoVadis for Sustainability Performance Creating a Culture of Innovation and Inclusivity at Avantor: Developing Our Associates Creating a Culture of Innovation and Inclusivity at Avantor: Reaching Our Future Associates Avantor® Announces Plans for New and Expanded Bridgewater, N.J. Innovation Center Avantor® Names R. Brent Jones as Chief Financial Officer Avantor’s Stubblefield Talks Innovation, Sustainability With Axios Avantor® to Host Second Quarter 2023 Earnings Call on Friday, July 28, 2023 Avantor(R) Launches Responsible Supplier Program Avantor® Launches Responsible Supplier Program Avantor(R) 2023 Sustainability Report: Message From Our CEO Comparator Drug Sourcing Market to Expand at 3.5% CAGR from 2023 to 2031|Growth Market Reports Avantor® Releases 2023 Science for Goodness Sustainability Report Avantor® and Labguru Collaborate to Drive More Efficient Lab Buying Experience Avantor® to Participate in Bernstein's 39th Annual Strategic Decisions Conference Avantor® Announces CFO Transition Avantor® to Participate in BofA Securities 2023 Health Care Conference Avantor® Reports First Quarter 2023 Results Avantor® Announces Supplier Award Winners at Americas Sales Conference Avantor® to Host First Quarter 2023 Earnings Call on Friday, April 28, 2023 Avantor® to Present at Upcoming Investor Conferences Avantor® Reports Fourth Quarter and Full-Year 2022 Results Avantor® and Avantor Foundation Giving Supports Communities Around the Globe in 2022 Avantor® and Catalent Enter into Multi-Year Supply and Services Agreement Avantor® to Report Fourth Quarter and Full Year 2022 Earnings and Host Earnings Call on Friday, February 3, 2023 Avantor® to Participate in the 41st Annual J.P. Morgan Healthcare Conference Avantor® to Participate in the 5th Annual Evercore ISI HealthCONx Conference Avantor® Continues Investment to Support Biopharma Market with Opening of New Distribution Center in Dublin, Ireland Avantor® Reports Third Quarter 2022 Results Avantor® to Host Third Quarter 2022 Earnings Call on Friday, October 28, 2022 Avantor® to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference Avantor® Reports Second Quarter 2022 Results Avantor® Names Kitty Sahin Executive Vice President, Strategy and Corporate Development Avantor® to Host Second Quarter 2022 Earnings Call on Friday, July 29, 2022 Avantor® to Collaborate with GeminiBio to Bring Custom Hydrated Solutions and Cell Culture Media to Biopharma Customers Avantor® to Participate in the 43rd Annual Goldman Sachs Global Healthcare Conference Avantor® Releases 2022 Sustainability Report, Highlighting Significant Progress in Environmental, Social and Governance (ESG) Efforts Avantor® Announces Conversion of Mandatory Convertible Preferred Stock Jonathan Peacock Elected Chairman of the Board of Directors of Avantor® Avantor® and Cytovance Biologics Collaborate to Accelerate Plasmid DNA Development for Biopharma Customers Avantor® Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry Avantor® Reports First Quarter 2022 Results Avantor® Declares Dividend on Mandatory Convertible Preferred Stock Avantor® to Report First Quarter 2022 Results and Host Earnings Call on April 29, 2022 Avantor® to Participate in KeyBanc Life Sciences and Medtech Investor Forum Avantor® to Participate in Barclays Global Healthcare Conference 2022 Avantor® to Participate in 42nd Annual Cowen Healthcare Conference Avantor® Announces Planned Retirement of Rajiv Gupta, Board Chairman Avantor® Reports Fourth Quarter and Full-Year 2021 Results Avantor® Declares Dividend on Mandatory Convertible Preferred Stock Avantor® to Report Fourth Quarter and Full Year 2021 Results and Host Earnings Call on February 4, 2022 Greg Mayer Joins Argosy Healthcare Partners CORRECTING AND REPLACING: Avantor to Participate in the 40th Annual J.P. Morgan Healthcare Conference Avantor® Opens Single-Use Logistics Hub to Strengthen Global Biopharma Supply Chain Avantor® to Participate in the 40th Annual J.P. Morgan Healthcare Conference Avantor® to Participate in the Evercore ISI 4th Annual HealthCONx Conference Avantor® Completes Acquisition of Masterflex® Avantor® Reports Third Quarter 2021 Results Avantor® Opens Second European Single-use Facility in the Netherlands; Supports Growing Demand for Bioproduction Avantor® Declares Dividend on Mandatory Convertible Preferred Stock Avantor® Announces Pricing of Offering of $800 Million of Senior Notes Avantor® Announces Offering of Senior Notes Avantor® Announces Preliminary Third Quarter Unaudited Revenues Avantor® to Report Third Quarter 2021 Earnings and Host Earnings Call on Friday, October 29, 2021 Avantor® Announces Pricing of Common Stock Offering Avantor® Announces Offering of Common Stock Avantor® to Acquire Masterflex®; Expands Proprietary Single-Use Offering for Bioproduction Avantor® Announces Investment in Hydration Capabilities to Address Growing Demand for Biologics Avantor® to Host Virtual Investor Day Avantor® Reports Second Quarter 2021 Results Avantor® Publishes Inaugural Sustainability Report; Drives Positive Impact through Science for Goodness Platform Avantor® Declares Dividend on Mandatory Convertible Preferred Stock Avantor® Announces Date Change for Second Quarter 2021 Earnings Release and Conference Call Avantor® to Report Second Quarter 2021 Earnings and Host Earnings Call on Wednesday, July 28, 2021 Avantor® Completes Acquisition of Ritter GmbH and its Affiliates Avantor® Acquires RIM Bio; Expands Bioproduction Footprint into China Avantor® to Present at Goldman Sachs 42nd Annual Global Healthcare Conference Avantor® Reports First Quarter 2021 Results Avantor® to Present at BofA Securities 2021 Virtual Health Care Conference Avantor® to Boost Global Production of Single­-Use Technologies and Address Growing Biopharma Demand Avantor® Declares Dividend on Mandatory Convertible Preferred Stock Avantor® to Acquire Ritter GmbH and its Affiliates; Expands Proprietary Offering for Diagnostic and Drug Discovery Workflows Avantor® to Report First Quarter 2021 Earnings and Host Earnings Call on Wednesday, April 28, 2021 Avantor® Announces Credit Rating Upgrade by Moody's Investors Services Avantor® to Participate at the Raymond James 42nd Annual Institutional Investor Conference Avantor® Announces Credit Rating Upgrade by S&P Global Ratings Avantor® Reports Fourth Quarter and Full-Year 2020 Results Avantor® Declares Dividend on Mandatory Convertible Preferred Stock Avantor® to Report Fourth Quarter and Full Year 2020 Earnings and Host Earnings Call on Wednesday, February 3, 2021 Avantor® Announces Preliminary Fourth Quarter Unaudited Revenues and Estimated Free Cash Flow Avantor® Sets Science in Motion for Goodness with Donations and Grants to Community-Based Organizations Avantor® to Present at the 39th Annual J.P. Morgan Healthcare Conference Avantor® to Participate at the Evercore ISI 3rd Annual HealthCONx Virtual Conference Avantor® Opens New Biorepository Facility in Europe to Support Growing Demand for Scientific Research and Clinical Trial Sample Storage Avantor® to Present at the Jefferies Virtual London Healthcare Conference G-CON Manufacturing Collaborates with Avantor® to Fast-Track Diagnostic Testing Avantor® Announces Pricing of Upsized Secondary Offering Avantor® Announces Secondary Offering of 71,339,001 Shares of Common Stock Avantor® Discusses Cell & Gene Therapy Production Trends Through the Lens of COVID-19 Avantor® Announces Upsizing and Pricing of Offering of €650.0 Million of Senior First Lien Notes Avantor® Announces Offering of Senior First Lien Notes Avantor® Reports Third Quarter 2020 Results and Announces Time Change for Earnings Call Avantor® Announces Preliminary Third Quarter Unaudited Revenues Avantor® Declares Dividend on Mandatory Convertible Preferred Stock Avantor's General Counsel Justin Miller Honored as "Legend in Law" by The Burton Awards Program Avantor® to Report Third Quarter Earnings and Host Earnings Call on Wednesday, October 28, 2020 Avantor® Appoints Frederic Vanderhaegen Executive Vice President, Americas and Europe Avantor® to Present at the Morgan Stanley Virtual Healthcare Conference Avantor® to Present at the 2020 Wells Fargo Virtual Healthcare Conference Avantor® Announces Pricing of Upsized Secondary Offering Avantor® Announces Secondary Offering of 38,500,000 Shares of Common Stock Avantor Announces Credit Rating Upgrade by S&P Global Ratings Avantor® Reports Second Quarter 2020 Results Avantor® Announces Upsizing and Pricing of Offering of $2.0 Billion Equivalent of Senior Notes Avantor® Announces Offering of Senior Notes Avantor® Named to Fortune 500 List Avantor® Declares Dividend on Mandatory Convertible Preferred Stock Avantor® Announces Preliminary Second Quarter 2020 Unaudited Revenue Avantor® Expands Life Sciences Innovation Center to Address Bioprocessing Needs in Protein Science, Monoclonal Antibodies (mAbs), Cell and Gene Therapy